0.9% sodium chloride - inhalation solution, ARO-MUC5AC Inhalation Solution clinical trials

A Phase 1/2a Study Evaluating the Effects of ARO-MUC5AC Inhalation Solution in Healthy Subjects and Patients with Muco-Obstructive Lung Disease

This study is testing a new inhaled medicine, ARO-MUC5AC, for people with lung conditions like asthma and COPD. It's looking to see if the medicine is safe and if it causes any side effects. Researchers will also check how the medicine works in the body.